Eton Pharmaceutcials Inc (ETON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 39,011 | 31,642 | 21,251 | 21,832 | 39 |
| Cost of Goods | 15,600 | 10,581 | 6,933 | 2,827 | 436 |
| Gross Profit | 23,411 | 21,061 | 14,318 | 19,005 | -397 |
| Operating Expenses | 26,608 | 22,834 | 23,511 | 21,327 | 27,150 |
| Operating Income | -2,597 | -1,192 | -8,260 | -1,495 | -27,111 |
| Other Income | -1,211 | 503 | -761 | -460 | -859 |
| Pre-tax Income | -3,808 | -689 | -9,021 | -1,955 | -27,970 |
| Income Tax | 15 | 247 | N/A | N/A | N/A |
| Net Income Continuous | -3,823 | -936 | -9,021 | -1,955 | -27,970 |
| Net Income | $-3,823 | $-936 | $-9,021 | $-1,955 | $-27,970 |
| EPS Basic Total Ops | -0.15 | -0.04 | -0.36 | -0.08 | -1.33 |
| EPS Basic Continuous Ops | -0.15 | -0.04 | -0.36 | -0.08 | -1.33 |
| EPS Diluted Total Ops | -0.15 | -0.04 | -0.36 | -0.08 | -1.33 |
| EPS Diluted Continuous Ops | -0.15 | -0.04 | -0.36 | -0.08 | -1.33 |
| EPS Diluted Before Non-Recurring Items | -0.15 | -0.04 | -0.36 | -0.08 | -1.33 |
| EBITDA(a) | $-342 | $-174 | $-6,359 | $-885 | $-26,339 |